Bodo Brunner

1.2k citations

19 papers · 921 indexed · h-index 10

Impact in

Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Physiology top 5%
- Reproductive biology and impacts on aquatic species

Papers in

Molecular Biology 15
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 4
- Genomics, phytochemicals, and oxidative stress 2
- CRISPR and Genetic Engineering 2
- Histone Deacetylase Inhibitors Research 2
Biochemistry 1

Co-authors: Almut Nitsche Clemens D. Cohen Anna Henger Holger Schmid Peter J. Nelson Matthias Kretzler Anissa Boucherot Markus Bleich
Journals: Journal of Medicinal Chemistry (3 papers)Diabetes (2 papers)Molecular Metabolism (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Pharmaceutics (1 paper)
Partner nations: Germany United States France

In The Last Decade

Bodo Brunner

18 papers receiving 910 citations

Peers

Countries citing papers authored by Bodo Brunner

Since Specialization

Citations

This map shows the geographic impact of Bodo Brunner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodo Brunner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodo Brunner more than expected).

Fields of papers citing papers by Bodo Brunner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bodo Brunner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodo Brunner. The network helps show where Bodo Brunner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bodo Brunner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bodo Brunner Line = papers co-authored together Bodo Brunner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Trivalent siRNA-Conjugates with Guanosine as ASGPR-Binder Show Potent Knock-Down In Vivo Journal of Medicinal Chemistry ·Morgan R Light, Kerstin Jahn‐Hofmann, Bodo Brunner, Mike W. Helms, W. Emboden, Gupta SS, Gernot Zech, Ziyu Li, Gerhard Heßler, Herman Schreuder, Bettina Elshorst, Megan Lechleitner, Michael Kurz, Bakul Tikoo, Sabine Scheidler	2025	0
2	Small Interfering RNAs Containing Dioxane- and Morpholino-Derived Nucleotide Analogues Show Improved Off-Target Profiles and Chirality-Dependent In Vivo Knock-Down Journal of Medicinal Chemistry ·Morgan R Light, Kerstin Jahn‐Hofmann, Bodo Brunner, Mike W. Helms, W. Emboden, Megan Lechleitner, Michael Kurz, Bakul Tikoo, Sabine Scheidler	2022	4
3	Syntheses of Morpholine-Based Nucleotide Analogs for Hepatic siRNA Targeting and Stabilization Journal of Medicinal Chemistry ·Morgan R Light, Kerstin Jahn‐Hofmann, Bodo Brunner, Mike W. Helms, W. Emboden, Megan Lechleitner, Michael Kurz, Ziyu Li, Daniel Floss Jones, Elaina Pasangha, Oliver Plettenburg, Sabine Scheidler	2021	4
4	Nanobody–siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells Molecular Pharmaceutics ·John R. Bertram, Bodo Brunner, Peter Casteels, M.R. Mc Neil, A. Gandhimathi, Carlo Boutton, Mike W. Helms, Timothy R. Wagenaar, K. Cullis, V V Razevig, W. Emboden, Pieter Deschaght, Sabine Scheidler, Kerstin Jahn‐Hofmann	2021	23
5	Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice Frontiers in Endocrinology ·Nicole Ziegler, Suryaprakash Raichur, Bodo Brunner, Ulrike Hemmann, M Stolte, Uwe Schwahn, Miguel Guillem Vilella, W. Emboden, Norbert Tennagels, Daniel Margerie, Paulus Wohlfart, Maximilian Bielohuby	2020	9
6	Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy Molecular Cancer Therapeutics ·Mike W. Helms, Kerstin Jahn‐Hofmann, Felix Gnerlich, W. Emboden, Monika Braun, Christopher W. Grote, Adolphe Aganze, Kaj Grandien, Joachim Theilhaber, Hui Cao, Timothy R. Wagenaar, Max Schnurr, Stefan Endres, Dmitri Wiederschain, Sabine Scheidler, Simon Rothenfußer, Bodo Brunner, Lars M. König	2019	13
7	The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach Molecular Metabolism ·Suryaprakash Raichur, Bodo Brunner, Maximilian Bielohuby, Gitte Hansen, Anja Pfenninger, L. Jason, Jens C. Brüning, Philip J. Larsen, Norbert Tennagels	2019	143
8	Liver-Specific siRNA Inhibition of Class 2a Histone Deacetylases (HDACs) Reduces Expression of Genes Regulating Gluconeogenesis in Primary Human and Mouse Hepatocytes, but Not in Mice Diabetes ·Sven W. Görgens, Jeong Suk Oh, Paulus Wohlfart, Bodo Brunner, Norbert Tennagels, Maximilian Bielohuby	2018	1
9	Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice Molecular Metabolism ·Sebastian Brachs, Sam Stapleton, Hui Tang, Andreas L. Birkenfeld, Bodo Brunner, Kerstin Jahn‐Hofmann, Daniel Margerie, Hartmut Ruetten, Dieter Schmoll, Joachim Spranger	2016	46
10	Chronic Activation of Hepatic Nrf2 Has No Major Effect on Fatty Acid and Glucose Metabolism in Adult Mice PLoS ONE ·Sebastian Brachs, Sam Stapleton, Linwu Miao, Hui Tang, Hooman Fazlalizadeh, Daniel Margerie, Bodo Brunner, Kerstin Jahn‐Hofmann, Hartmut Ruetten, Joachim Spranger, Dieter Schmoll	2016	4
11	Pau d’arco activates Nrf2-dependent gene expression via the MEK/ERK-pathway The Journal of Toxicological Sciences ·Michelle F. Richter, Sam Stapleton, Dietmar Schummer, Martin Gerlitz, Leora Sas, Bodo Brunner, Maike Glien, Dieter Schmoll	2014	8
12	Sequence based high resolution chromosomal CGH Cytogenetic and Genome Research ·Elizabeth L. Pierce Davis, Bodo Brunner, Eva Bozsaky, Emaan Shahid, Magdalena Cortés, Thomas Lörch, 袁丹, Peter F. Ambros	2008	3
13	Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy Diabetes ·Holger Schmid, Anissa Boucherot, Yoshinari Yasuda, Anna Henger, Bodo Brunner, Felix Eichinger, Almut Nitsche, Éva Kiss, Markus Bleich, Hermann‐Josef Gröne, Peter J. Nelson, Detlef Schlöndorff, Clemens D. Cohen, Matthias Kretzler	2006	328
14	Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins Proceedings of the National Academy of Sciences ·Clemens D. Cohen, Andreas Klingenhoff, Anissa Boucherot, Almut Nitsche, Anna Henger, Bodo Brunner, Holger Schmid, Monika Merkle, Moin A. Saleem, Anandkumar K.M, Thomas Werner, Hermann-Josef Gröne, Peter J. Nelson, Matthias Kretzler	2006	95
15	Oligonucleotide‐Based Knockdown Technologies: Antisense Versus RNA Interference ChemBioChem ·達也平野, Bodo Brunner, Kathrin Heermeier	2003	56
16	Oligonucleotide‐Based Knockdown Technologies: Antisense versus RNA Interference ChemInform ·達也平野, Bodo Brunner, Kathrin Heermeier	2003	2
17	Genomic Organization and Expression of the Doublesex-Related Gene Cluster in Vertebrates and Detection of Putative Regulatory Regions for DMRT1 Genomics ·Bodo Brunner, Ute Hornung, ryuta koide, Indrajit Nanda, Mariko Kondo, D. Salvatore, Thomas Haaf, Hans‐Hilger Ropers, Akihiro Shima, Michael Schmid, Vera M. Kalscheuer, Manfred Schartl	2001	129
18	Molecular cloning and characterization of the Fugu rubripes MEST/COPG2 imprinting cluster and chromosomal localization in Fugu and Tetraodon nigroviridis Chromosome Research ·Bodo Brunner, Frank Grützner, Marie‐Laure Yaspo, Hans‐Hilger Ropers, Thomas Haaf, Vera M. Kalscheuer	2000	13
19	Genomic Structure and Comparative Analysis of Nine Fugu Genes: Conservation of Synteny with Human Chromosome Xp22.2–p22.1 Genome Research ·Bodo Brunner, Nelson Ssemambo, Steffen Lenzner, Karen Stout, Sarah Aparecida Gonçalves da Silva, H.H. Ropers, Vera M. Kalscheuer	1999	40

About Bodo Brunner

Bodo Brunner is a scholar working on Molecular Biology, Biochemistry, Cellular and Molecular Neuroscience, Clinical Biochemistry and Nephrology, having authored 19 papers that have together received 921 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (4 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Adipose Tissue and Metabolism (2 papers), CRISPR and Genetic Engineering (2 papers), Nuclear Receptors and Signaling (2 papers), Chromosomal and Genetic Variations (2 papers) and Histone Deacetylase Inhibitors Research (2 papers). The work is most often cited by research in Nephrology (181 citations), Physiology (58 citations), Clinical Biochemistry (76 citations), Genetics (234 citations) and Molecular Biology (485 citations). Bodo Brunner has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Almut Nitsche, Clemens D. Cohen, Anna Henger, Holger Schmid, Peter J. Nelson, Matthias Kretzler, Anissa Boucherot, Markus Bleich, Felix Eichinger and Hermann‐Josef Gröne. Their work appears in journals such as Journal of Medicinal Chemistry, Diabetes, Molecular Metabolism, Molecular Cancer Therapeutics and Molecular Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact